Vaso-occlusive crisis in sickle cell disease: a vicious cycle of secondary events

Painful vaso-occlusive crisis (VOC) remains the most common reason for presenting to the Emergency Department and hospitalization in patients with sickle cell disease (SCD). Although two new agents have been approved by the Food and Drug Administration for treating SCD, they both target to reduce th...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Tim, Poplawska, Maria, Cimpeanu, Emanuela, Mo, George, Dutta, Dibyendu, Lim, Seah H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454100/
https://www.ncbi.nlm.nih.gov/pubmed/34544432
http://dx.doi.org/10.1186/s12967-021-03074-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454100/
https://www.ncbi.nlm.nih.gov/pubmed/34544432
http://dx.doi.org/10.1186/s12967-021-03074-z

Ejemplares similares